Literature DB >> 8347291

Epidemiology of drug-drug interactions as a cause of hospital admissions.

C A Jankel1, L K Fitterman.   

Abstract

The purpose of this review was to focus on hospital admissions caused by a specific type of adverse drug reaction (ADR) that can be assumed to be avoidable in almost all cases: the drug-drug interaction (D-DI). To determine the epidemiology of D-DIs in hospital admissions, a review of the adverse drug reaction literature was undertaken to answer several questions: (a) what is the incidence of hospital admissions attributable to D-DIs?; (b) what percentage of drug-related hospital admissions are attributable to D-DIs?; (c) are there any patterns to the above findings, i.e. are some D-DIs or specific drugs more likely to have been associated with hospital admissions?; and (d) are there certain patient risk factors (e.g. age) that are associated with D-DIs that led to a hospital admission? Nine ADR studies were found that either included a D-DI category as a cause for hospital admissions, or provided sufficient information so that a causal relationship could be inferred. The incidence of hospital admissions due to D-DIs ranged from 0 to 2.8%. The data found in the studies we reviewed, however, were insufficient to allow meaningful quantification of specific drugs as usual causes for D-DI-related admissions, and because of the very small numbers of patients for which a D-DI was believed to be the cause it is not possible to provide a meaningful summary of risk factors specific for D-DI admissions. We cannot conclude that D-DIs are a significant problem. There is a need to view the quantification of D-DIs in relation to the number of medications prescribed by physicians, dispensed by pharmacists and taken by patients.

Entities:  

Mesh:

Year:  1993        PMID: 8347291     DOI: 10.2165/00002018-199309010-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  30 in total

1.  Drug related admissions to medical wards: a population based survey.

Authors:  J Hallas; L F Gram; E Grodum; N Damsbo; K Brøsen; T Haghfelt; B Harvald; J Beck-Nielsen; J Worm; K B Jensen
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

2.  Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department.

Authors:  F Davidsen; T Haghfelt; L F Gram; K Brøsen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Adverse drug reactions leading to hospital admission.

Authors:  L Ibáñez; J R Laporte; X Carné
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

4.  Community-hospital pharmacist detection of drug-related problems upon patient admission to small hospitals.

Authors:  P A Frisk; J W Cooper; N A Campbell
Journal:  Am J Hosp Pharm       Date:  1977-07

5.  Drug-induced illness leading to hospitalization.

Authors:  G J Caranasos; R B Stewart; L E Cluff
Journal:  JAMA       Date:  1974-05-06       Impact factor: 56.272

6.  Assessment of adverse reactions within a drug surveillance program.

Authors:  I T Borda; D Slone; H Jick
Journal:  JAMA       Date:  1968-08-26       Impact factor: 56.272

7.  Adverse drug reactions during hospitalization.

Authors:  R I Ogilvie; J Ruedy
Journal:  Can Med Assoc J       Date:  1967-12-09       Impact factor: 8.262

8.  Drug-related emergency department visits and hospital admissions.

Authors:  B S Prince; C M Goetz; T L Rihn; M Olsky
Journal:  Am J Hosp Pharm       Date:  1992-07

9.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01

10.  Drug-induced illness as a cause for admission to a community hospital.

Authors:  H G Colt; A P Shapiro
Journal:  J Am Geriatr Soc       Date:  1989-04       Impact factor: 5.562

View more
  60 in total

Review 1.  ["Clinically significant" new drug interactions].

Authors:  U Fuhr
Journal:  Med Klin (Munich)       Date:  1999-02-15

2.  Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.

Authors:  Roberto Leone; Lara Magro; Ugo Moretti; Paola Cutroneo; Martina Moschini; Domenico Motola; Marco Tuccori; Anita Conforti
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

3.  Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study.

Authors:  A P Jonville-Béra; F Béra; E Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2005-04-12       Impact factor: 2.953

Review 4.  Potential determinants of drug-drug interaction associated dispensing in community pharmacies.

Authors:  Matthijs L Becker; Marjon Kallewaard; Peter W J Caspers; Tom Schalekamp; Bruno H C Stricker
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.

Authors:  Henk Buurma; Peter A G M De Smet; Antoine C G Egberts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland.

Authors:  Jörg Indermitte; Laura Erba; Marianne Beutler; Rudolf Bruppacher; Walter E Haefeli; Kurt E Hersberger
Journal:  Eur J Clin Pharmacol       Date:  2007-01-11       Impact factor: 2.953

7.  Evaluation of frequently used drug interaction screening programs.

Authors:  Priska Vonbach; André Dubied; Stephan Krähenbühl; Jürg H Beer
Journal:  Pharm World Sci       Date:  2008-04-16

8.  Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999.

Authors:  Laurence Guédon-Moreau; Dominique Ducrocq; Marie-Francoise Duc; Yves Quieureux; Catherine L'Hôte; Jean Deligne; Jacques Caron
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

9.  Content and Usability Evaluation of Patient Oriented Drug-Drug Interaction Websites.

Authors:  Terrence J Adam; Joseph Vang
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

10.  Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999.

Authors:  Laurence Guédon-Moreau; Dominique Ducrocq; Marie-Francoise Duc; Yves Quieureux; Catherine L'Hôte; Jean Deligne; Jacques Caron
Journal:  Eur J Clin Pharmacol       Date:  2003-10-14       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.